Patent US7393360B2 successfully refreshed from Google Patents.
US7393360B2
Expired / Lapsed
US
⏱️ 0.0 years remaining
Implantable prosthetic valve
Assignee: Edwards Lifesciences PVT Inc
•
Filing: 2005-01-28
•
Granted: 2008-07-01
•
Expires: 2025-01-28
Abstract
Abstract A valve prosthesis device is disclosed suitable for implantation in body ducts. The device comprises support stent, comprised of a deployable construction adapted to be initially crimped in a narrow configuration suitable for catheterization through the body duct to a target location and adapted to be deployed by exerting substantially radial forces from within by means of a deployment device to a deployed state in the target location, the support stent provided with a plurality of longitudinally rigid support beams of fixed length; valve assembly comprising a flexible conduit having an inlet end and an outlet, made of pliant material attached to the support beams providing collapsible slack portions of the conduit at the outlet. When flow is allowed to pass through the valve prosthesis device from the inlet to the outlet the valve assembly is kept in an open position, whereas a reverse flow is prevented as the collapsible slack portions of the valve assembly collapse inwardly providing blockage to the reverse flow.
Inventors
- 👤 Benjamin Spenser
- 👤 Netanel Benichu
- 👤 Assaf Bash
- 👤 Avraham Zakai
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 06:35
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/02; A61F2/24; A61F2/2412; A61F2/2418; A61F2/2427; A61F2/243; A61F2/2433; A61F2/2436; A61F2/95; A61F2/9522; A61F2/9524; A61F2/2403; A61F2/2409; A61F2/2415; A61F2/2421; A61F2/2442; A61F2/2463; A61F2/82; A61F2210/00; A61F2210/0014; A61F2220/00; A61F2220/0008; A61F2220/0016; A61F2220/0025; A61F2220/0075; A61F2220/0083; A61F2230/00; A61F2230/0002; A61F2230/0028; A61F2230/0054; A61F2230/0063; A61F2230/0069; A61F2250/00; A61F2250/0004; A61F2250/001; A61F2250/0058; A61F2250/0096; A61F2250/0098
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
264 words
A method for deploying a valve device at the natural aortic valve position at the entrance to the left ventricle of a myocardium of a patient, comprising: radially collapsing a deployable implantable valve device having a collapsible and expandable support stent and a collapsible and expandable valve assembly, the support stent comprising a first portion configured to expand to a first diameter and a second portion configured to expand to a second diameter, the first diameter being smaller than the second diameter and wherein the valve assembly is sutured to the support stent; advancing the collapsed valve device through the patient's vasculature towards the natural aortic valve position via a catheterization technique; positioning the valve device such that the valve assembly is located substantially within an annulus of a natural aortic valve; and radially expanding the first and second portions such that the first portion engages leaflets of the natural aortic valve and the second portion engages an inner wall of an ascending aorta above the opening of the coronary arteries; wherein, after implantation, the valve assembly allows blood to flow in a first direction and prevents blood from flowing in a second direction and wherein the first and second portions of the support stent are configured to resist migration of the valve assembly; wherein, after implantation, the support stent has a third diameter positioned at the level of the coronary arteries, the third diameter being substantially less than an inner diameter of the ascending aorta such that a radial gap is provided between the support stent and the opening of the coronary arteries.
Claim 2
Independent Claim
264 words
A method for deploying a valve device at the natural aortic valve position at the entrance to the left ventricle of a myocardium of a patient, comprising: radially collapsing a deployable implantable valve device having a collapsible and expandable support stent and a collapsible and expandable valve assembly, the support stent comprising a first portion configured to expand to a first diameter and a second portion configured to expand to a second diameter, the first diameter being smaller than the second diameter and wherein the valve assembly is sutured to the support stent; advancing the collapsed valve device through the patient's vasculature towards the natural aortic valve position via a catheterization technique; positioning the valve device such that the valve assembly is located substantially within an annulus of a natural aortic valve; and radially expanding the first and second portions such that the first portion engages leaflets of the natural aortic valve and the second portion engages an inner wall of an ascending aorta above the opening of the coronary arteries; wherein, after implantation, the valve assembly allows blood to flow in a first direction and prevents blood from flowing in a second direction and wherein the first and second portions of the support stent are configured to resist migration of the valve assembly; wherein, after implantation, the support stent has a third diameter positioned at the level of the coronary arteries, the third diameter being substantially less than an inner diameter of the ascending aorta such that a radial gap is provided between the support stent and the opening of the coronary arteries.
Claim 3
Dependent Claim
26 words
The method of claim 1 , further comprising advancing a guidewire through the patient's vasculature to facilitate advancement of the valve device via a catheterization technique.
Claim 4
Dependent Claim
20 words
The method of claim 2 , wherein the valve device is advanced over the guidewire and around the aortic arch.
Claim 5
Dependent Claim
28 words
The method of claim 1 , wherein a balloon catheter is used to assist in the radial expansion of the first and second portions of the support stent.
Claim 6
Dependent Claim
38 words
The method of claim 4 , wherein the balloon catheter has a first inflatable portion for expanding the first portion of the support stent and a second inflatable portion for expanding the second portion of the support stent.
Claim 7
Dependent Claim
15 words
The method of claim 1 , wherein the valve assembly is formed of natural tissue.
Claim 8
Dependent Claim
15 words
The method of claim 1 , wherein the valve assembly is formed of pericardial tissue.
Claim 9
Dependent Claim
17 words
The method of claim 1 , wherein the support stent is formed of a shape memory alloy.
Claim 10
Dependent Claim
20 words
The method of claim 1 , wherein the valve assembly is adhered to the first portion of the support stent.
Claim 11
Independent Claim
288 words
A method for deploying a valve device at the natural aortic valve position at the entrance to the left ventricle of a myocardium of a patient, comprising: radially collapsing an implantable valve device having a collapsible and expandable support stent formed of a shape memory material and a collapsible and expandable valve assembly formed of pericardial tissue, the support stent comprising a lower portion configured to expand to a first diameter and an upper portion configured to expand to a second diameter, the first diameter being smaller than the second diameter and wherein the valve assembly is sutured to the support stent at an inlet end and is sutured to the support stent along three commissural points for support three valve leaflets; advancing a guidewire through the patient's vasculature and around the aortic arch; advancing the collapsed valve device over the guidewire towards the natural aortic valve position via a catheterization technique; positioning the valve device such that the valve assembly is located within an annulus of a natural aortic valve; and radially expanding the support stent such that the lower portion engages leaflets of the natural aortic valve and the upper portion engages an inner wall of an ascending aorta; wherein, after implantation, the valve assembly allows blood to flow in a first direction and prevents blood from flowing in a second direction and wherein the lower and upper portions of the support stent are configured to resist migration of the valve assembly; wherein the support stent further comprises a central portion between the lower and upper portion, the central portion being shaped to provide a radial gap between the support stent and the inner wall of the ascending aorta at the openings of the coronary arteries.
Claim 12
Independent Claim
288 words
A method for deploying a valve device at the natural aortic valve position at the entrance to the left ventricle of a myocardium of a patient, comprising: radially collapsing an implantable valve device having a collapsible and expandable support stent formed of a shape memory material and a collapsible and expandable valve assembly formed of pericardial tissue, the support stent comprising a lower portion configured to expand to a first diameter and an upper portion configured to expand to a second diameter, the first diameter being smaller than the second diameter and wherein the valve assembly is sutured to the support stent at an inlet end and is sutured to the support stent along three commissural points for support three valve leaflets; advancing a guidewire through the patient's vasculature and around the aortic arch; advancing the collapsed valve device over the guidewire towards the natural aortic valve position via a catheterization technique; positioning the valve device such that the valve assembly is located within an annulus of a natural aortic valve; and radially expanding the support stent such that the lower portion engages leaflets of the natural aortic valve and the upper portion engages an inner wall of an ascending aorta; wherein, after implantation, the valve assembly allows blood to flow in a first direction and prevents blood from flowing in a second direction and wherein the lower and upper portions of the support stent are configured to resist migration of the valve assembly; wherein the support stent further comprises a central portion between the lower and upper portion, the central portion being shaped to provide a radial gap between the support stent and the inner wall of the ascending aorta at the openings of the coronary arteries.
Claim 13
Dependent Claim
31 words
The method of claim 10 , further comprising inflating a balloon within the valve device to assist in the radial expansion of the lower and upper portions of the support stent.
References Cited (Backward Citations)
US3409013A
Cited
US3587115A
Cited
US3548417A
Cited
US3671979A
Cited
US3657744A
Cited
US3714671A
Cited
US3755823A
Cited
US4035849A
Cited
US4106129A
Cited
US4056854A
Cited
US4297749A
Cited
US4222126A
Cited
US4265694A
Cited
US4574803A
Cited
GB2056023B
Cited
US4343048A
Cited
US4373216A
Cited
US4339831A
Cited
US4470157A
Cited
US4345340A
Cited
US4406022A
Cited
US4655771A
Cited
US4655771B1
Cited
EP0103546B1
Cited
US4605407A
Cited
US4535483A
Cited
US4612011A
Cited
EP0144167B1
Cited
US4787899A
Cited
US5026366A
Cited
US4592340A
Cited
US4979939A
Cited
US4787901A
Cited
US4643732A
Cited
SU1271508A1
Cited
US4759758A
Cited
US4733665C2
Cited
US4733665B1
Cited
US4733665A
Cited
US4922905A
Cited
SU1371700A1
Cited
US4692164A
Cited
US4878906A
Cited
US4777951A
Cited
US4883458A
Cited
US4878495A
Cited
US4796629A
Cited
US4829990A
Cited
US4851001A
Cited
US5032128A
Cited
US5080668A
Cited
US5007896A
Cited
US4856516A
Cited
US4966604A
Cited
US4994077A
Cited
US5500014A
Cited
US5609626A
Cited
US5047041A
Cited
US4986830A
Cited
US5089015A
Cited
US5037434A
Cited
US5059177A
Cited
US5840081A
Cited
WO1991017720A1
Cited
US6168614B1
Cited
US5085635A
Cited
US5411552A
Cited
US5152771A
Cited
US5282847A
Cited
US5607464A
Cited
US5360444A
Cited
US5443446A
Cited
US5295958A
Cited
WO1992017118A1
Cited
US5167628A
Cited
US5397351A
Cited
US5769812A
Cited
US5370685A
Cited
US5545214A
Cited
WO1993001768A1
Cited
EP0597967B1
Cited
US5163953A
Cited
US5332402A
Cited
US5411055A
Cited
US5549665A
Cited
US5545209A
Cited
US5480424A
Cited
US6302906B1
Cited
US5728068A
Cited
US5554185A
Cited
US5716417A
Cited
US5571175A
Cited
DE19532846A1
Cited
US5591195A
Cited
DE19546692C2
Cited
US6027525A
Cited
US5855601A
Cited
US5855602A
Cited
US5749890A
Cited
US6605112B1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2011-07-01 | 2011-12-31 | 2012-07-01 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2015-07-01 | 2015-12-31 | 2016-07-01 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2019-07-01 | 2019-12-31 | 2020-07-01 | $7700.00 | Window Closed / Lapsed |